Volume 20, Number 9—September 2014
CME ACTIVITY - Synopsis
Confirmed Bacillus anthracis Infection among Persons Who Inject Drugs, Scotland, 2009–2010
Table 3
Initial administration of antibacterial drugs to persons who inject drugs and had Bacillus anthracis Infection, Scotland, UK, 2009–2010*
7 | + | + | + | – | – | – | – | – | – | – | – | – |
---|---|---|---|---|---|---|---|---|---|---|---|---|
8 | + | – | + | + | – | – | + | – | – | – | – | – |
9 | + | + | – | – | + | + | + | + | + | + | – | – |
10 | + | + | – | – | + | + | – | – | – | – | – | – |
11 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
+ |
Total, n = 27 | 21 (78) | 18 (67) | 16 (59) | 16 (59) | 14 (52) | 5 (19) | 3 (11) | 3 (11) | 2 (7) | 1 (4) | 1 (4) | 1 (4) |
*CLI, clindamycin; CIP, ciprofloxacin; BPC, benzylpenicillin (penicillin G); FLUX, flucloxacillin; MTZ, metronidazole; CRO, ceftriaxone; GEN, gentamicin; VAN, vancomycin; MEM, meropenem; TZP, piperacillin/tazobactam; AMC, amoxicillin/clavulanic acid; AMX, amoxicillin; +, antibacterial drug administered; –, antibacterial drug not administered.
†Patients for whom data were available are numbered in the order in which they sought care during the outbreak.
‡No. (%) patients receiving an antibacterial drug.
1These authors contributed equally to this article.
Page created: August 15, 2014
Page updated: August 15, 2014
Page reviewed: August 15, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.